Medicare Enrolled
Dr. Shivtaj Mann, DO
Internal Medicine · Fort Myers, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mann from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mann?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mann
Dr. Shivtaj Mann is an internal medicine specialist in Fort Myers, FL, with 10 years of NPI registration. Based on federal Medicare data, Dr. Mann performed 76,514 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mann received a total of $7,096 from 62 pharmaceutical and/or device companies across 325 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mann is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 10 years of NPI registration
▲ Top 0% volume in FL
$7,096 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Osteopathic Physician | 18673 | Clear | March 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗76,514
Medicare services
Top 0% in FL for internal medicine
Not available
Unique patients (not deduplicated)
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
14,280 | $0 | $4 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
12,600 | $0 | $5 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
12,300 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
10,320 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 5,980 | $1 | $5 |
| Pembrolizumab injection (Keytruda) | 4,000 | $43 | $137 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
3,730 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 2,400 | $17 | $51 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
2,106 | $36 | $108 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,418 | $0 | $3 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,243 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,100 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 820 | $1 | $28 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
579 | $65 | $197 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
372 | $107 | $377 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
361 | $103 | $339 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
305 | $70 | $239 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
299 | $12 | $61 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
280 | $11 | $69 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
225 | $105 | $378 |
| Anti-nausea injection (ondansetron/Zofran) | 196 | $0 | $9 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
139 | $97 | $285 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
135 | $49 | $189 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
116 | $57 | $206 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
108 | $1 | $3 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
98 | $18 | $59 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
98 | $143 | $474 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
83 | $23 | $79 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
79 | $16 | $56 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
70 | $52 | $178 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
69 | $141 | $556 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
67 | $10 | $42 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
65 | $2 | $7 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
64 | $1 | $6 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
53 | $5 | $20 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
52 | $26 | $156 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
47 | $23 | $84 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
45 | $45 | $170 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
45 | $75 | $298 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
30 | $30 | $156 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
29 | $114 | $453 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
22 | $4 | $15 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
19 | $3 | $11 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
15 | $25 | $89 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
14 | $1 | $7 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
13 | $2 | $8 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
13 | $41 | $109 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
12 | $141 | $467 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
22.3% high complexity
71.7% medium
6.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,096
Total received (2018-2024)
Avg $1,014/year across 7 years
Top 10% in FL for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
325
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,751
2023
$2,517
2022
$723
2021
$100
2020
$194
2019
$448
2018
$363
Payments by company (2024)
Janssen Biotech, Inc.
$235
E.R. Squibb & Sons, L.L.C.
$203
Novartis Pharmaceuticals Corporation
$201
AstraZeneca Pharmaceuticals LP
$178
PFIZER INC.
$176
GlaxoSmithKline, LLC.
$172
TAIHO ONCOLOGY, INC.
$152
Daiichi Sankyo Inc.
$141
Merck Sharp & Dohme LLC
$130
Takeda Pharmaceuticals U.S.A., Inc.
$119
Celgene Corporation
$99
Eisai Inc.
$86
ADC Therapeutics America, Inc.
$76
Incyte Corporation
$70
Exelixis Inc.
$58
ARRAY BIOPHARMA INC
$56
GENZYME CORPORATION
$49
Amneal Pharmaceuticals LLC
$41
Agios Pharmaceuticals, Inc.
$39
TerSera Therapeutics LLC
$37
Adaptive Biotechnologies Corporation
$36
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
Rigel Pharmaceuticals, Inc.
$32
Stemline Therapeutics Inc.
$30
Astellas Pharma US Inc
$30
BeiGene USA, Inc.
$28
Lilly USA, LLC
$28
Alexion Pharmaceuticals, Inc.
$26
Myriad Genetic Laboratories, Inc.
$25
Bayer Healthcare Pharmaceuticals Inc.
$24
Acrotech Biopharma Inc.
$23
SpringWorks Therapeutics, Inc.
$22
ABBVIE INC.
$20
EMD Serono, Inc.
$20
Pharmacosmos Therapeutics Inc.
$17
Dendreon Pharmaceuticals LLC
$16
Fennec Pharmaceuticals, Inc.
$14
Iovance Biotherapeutics, Inc.
$9
Top 3 companies account for 23.2% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme LLC
$548
Janssen Biotech, Inc.
$497
E.R. Squibb & Sons, L.L.C.
$412
Novartis Pharmaceuticals Corporation
$383
Astellas Pharma US Inc
$344
PFIZER INC.
$338
Celgene Corporation
$285
Daiichi Sankyo Inc.
$268
GlaxoSmithKline, LLC.
$262
Takeda Pharmaceuticals U.S.A., Inc.
$260
Incyte Corporation
$239
AstraZeneca Pharmaceuticals LP
$218
Lilly USA, LLC
$199
GENZYME CORPORATION
$191
Seagen Inc.
$174
TAIHO ONCOLOGY, INC.
$152
Eisai Inc.
$151
BeiGene USA, Inc.
$124
Rigel Pharmaceuticals, Inc.
$123
Genentech USA, Inc.
$102
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$100
SANOFI-AVENTIS U.S. LLC
$100
Novo Nordisk Inc
$100
Adaptive Biotechnologies Corporation
$99
Regeneron Healthcare Solutions, Inc.
$89
ARRAY BIOPHARMA INC
$88
Janssen Pharmaceuticals, Inc
$86
Boehringer Ingelheim Pharmaceuticals, Inc.
$81
TerSera Therapeutics LLC
$80
Exelixis Inc.
$78
ADC Therapeutics America, Inc.
$76
Gilead Sciences, Inc.
$75
Bayer Healthcare Pharmaceuticals Inc.
$59
Pharmacyclics LLC, An AbbVie Company
$53
Agios Pharmaceuticals, Inc.
$53
Stemline Therapeutics Inc.
$48
CTI BioPharma Corp.
$42
Amneal Pharmaceuticals LLC
$41
Sobi, Inc
$36
Pharmacosmos Therapeutics Inc.
$30
Verastem, Inc.
$26
Bayer HealthCare Pharmaceuticals Inc.
$26
Alexion Pharmaceuticals, Inc.
$26
Myriad Genetic Laboratories, Inc.
$25
Acrotech Biopharma Inc.
$23
SpringWorks Therapeutics, Inc.
$22
SERVIER PHARMACEUTICALS LLC
$21
ABBVIE INC.
$20
PUMA BIOTECHNOLOGY, INC.
$20
EMD Serono, Inc.
$20
Foundation Medicine, Inc.
$19
MorphoSys, US Inc.
$18
Kyowa Kirin, Inc.
$18
Kite Pharma, Inc.
$17
Seattle Genetics, Inc.
$16
Dendreon Pharmaceuticals LLC
$16
Fennec Pharmaceuticals, Inc.
$14
Ipsen Biopharmaceuticals, Inc
$14
Sumitomo Pharma America, Inc.
$13
Alnylam Pharmaceuticals Inc.
$13
Amgen Inc.
$13
Iovance Biotherapeutics, Inc.
$9
Top 3 companies account for 20.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AVASTIN · Alecensa · Amtagvi · BELEODAQ · BOSULIF · BRAFTOVI · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · COSELA · CRESEMBA · Copiktra · DARZALEX · DOPTELET · ELAHERE · ELIQUIS · ELITEK · ELZONRIS · ENHERTU · ERLEADA · Enhertu · FRUZAQLA · Fabhalta · GILOTRIF · HYQVIA · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · Lenvima · MONJUVI · MONOFERRIC · MYRISK · NERLYNX · NINLARO · Nubeqa · OGSIVEO · OJJAARA · ONPATTRO · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Pedmark · Pomalyst · REBLOZYL · RETEVMO · RYBREVANT · Rezlidhia · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · Stivarga · TASIGNA · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · VERZENIO · VONVENDI · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XIFAXAN · XOSPATA · Xofigo · Xultophy 100/3.6 · ZEJULA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
476
County median income
$73,099
Nearest hospital to ZIP centroid (approximate)
GULF COAST MEDICAL CENTER LEE HEALTH
8.1 mi
8.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mann is a mixed practice specialist, with above-average Medicare volume (top 0% in FL).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mann experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Mann performed 14,280 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mann receive payments from pharmaceutical companies?
Yes. Dr. Mann received a total of $7,096 from 62 companies across 325 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mann's costs compare to other internal medicine physicians in Fort Myers?
Dr. Mann's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mann) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Fort Myers
Browse internal medicine physicians in Fort Myers ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in FL
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in FL
Which FL internal medicine physicians receive the most from drug and device companies.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology